全文获取类型
收费全文 | 310722篇 |
免费 | 51169篇 |
国内免费 | 2677篇 |
专业分类
耳鼻咽喉 | 6422篇 |
儿科学 | 9256篇 |
妇产科学 | 6508篇 |
基础医学 | 24351篇 |
口腔科学 | 9041篇 |
临床医学 | 52181篇 |
内科学 | 76991篇 |
皮肤病学 | 10011篇 |
神经病学 | 29236篇 |
特种医学 | 12384篇 |
外国民族医学 | 16篇 |
外科学 | 59225篇 |
综合类 | 807篇 |
现状与发展 | 80篇 |
一般理论 | 110篇 |
预防医学 | 30164篇 |
眼科学 | 6355篇 |
药学 | 9168篇 |
中国医学 | 265篇 |
肿瘤学 | 21997篇 |
出版年
2024年 | 756篇 |
2023年 | 7062篇 |
2022年 | 2237篇 |
2021年 | 5563篇 |
2020年 | 8718篇 |
2019年 | 4697篇 |
2018年 | 12096篇 |
2017年 | 12059篇 |
2016年 | 13270篇 |
2015年 | 13784篇 |
2014年 | 22122篇 |
2013年 | 25059篇 |
2012年 | 14038篇 |
2011年 | 14166篇 |
2010年 | 16034篇 |
2009年 | 20654篇 |
2008年 | 13555篇 |
2007年 | 11837篇 |
2006年 | 14301篇 |
2005年 | 10886篇 |
2004年 | 9005篇 |
2003年 | 7641篇 |
2002年 | 7206篇 |
2001年 | 9020篇 |
2000年 | 7954篇 |
1999年 | 7900篇 |
1998年 | 6086篇 |
1997年 | 5580篇 |
1996年 | 5622篇 |
1995年 | 5040篇 |
1994年 | 3580篇 |
1993年 | 3043篇 |
1992年 | 4531篇 |
1991年 | 4209篇 |
1990年 | 3738篇 |
1989年 | 3651篇 |
1988年 | 3288篇 |
1987年 | 2838篇 |
1986年 | 2766篇 |
1985年 | 2490篇 |
1984年 | 1850篇 |
1983年 | 1673篇 |
1982年 | 1166篇 |
1981年 | 991篇 |
1980年 | 819篇 |
1979年 | 1215篇 |
1978年 | 914篇 |
1977年 | 886篇 |
1974年 | 703篇 |
1972年 | 726篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
82.
83.
84.
85.
Anastasiia Panfilova Sarah E. Shelton Cristina Caresio Ruud J.G. van Sloun Filippo Molinari Hessel Wijkstra Paul A. Dayton Massimo Mischi 《Ultrasound in medicine & biology》2019,45(2):539-548
Dynamic contrast-enhanced ultrasound (DCE-US) has been proposed as a powerful tool for cancer diagnosis by estimation of perfusion and dispersion parameters reflecting angiogenic vascular changes. This work was aimed at identifying which vascular features are reflected by the estimated perfusion and dispersion parameters through comparison with acoustic angiography (AA). AA is a high-resolution technique that allows quantification of vascular morphology. Three-dimensional AA and 2-D DCE-US bolus acquisitions were used to monitor the growth of fibrosarcoma tumors in nine rats. AA-derived vascular properties were analyzed along with DCE-US perfusion and dispersion to investigate the differences between tumor and control and their evolution in time. AA-derived microvascular density and DCE-US perfusion exhibited good agreement, confirmed by their spatial distributions. No vascular feature was correlated with dispersion. Yet, dispersion provided better cancer classification than perfusion. We therefore hypothesize that dispersion characterizes vessels that are smaller than those visible with AA. 相似文献
86.
87.
88.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献
89.
90.
Marie V. Plaisime PhD MPH Marie Jipguep-Akhtar PhD Joseph J. Locascio PhD Harolyn M. E. Belcher MD MHS Rachel R. Hardeman PhD MPH Katherine Picho-Kiroga PhD Sylvia P. Perry PhD Sean M. Phelan PhD MPH Michelle van Ryn PhD LMFT MPH John F. Dovidio PhD 《Health services research》2023,58(Z2):229-237